Explorer les evidences

85,6 %An efficient viral load reduction to below 50 copies/ml was observed in 113 (85.6%) of the 132 patients who had been on ART for more than 6 months.

KenyaVIH/sidapublié 2009AIDS research and therapyeurope_pmcdocument de 8 observations

18 %Late ART refills occurred at 18% of postpartum visits among HIV-seropositive Kenyan women.

KenyaVIH/sidapublié 2021PloS oneeurope_pmcdocument de 2 observationsDOI 10.1371/journal.pone.0254767

18 %In a pragmatic randomized trial in rural western Kenya, disengagement from HIV care was 18% in the intervention group and 17% in the control group over one year of follow-up.

KenyaVIH/sidaobservé one year of follow-uppublié 2021PloS onePubMeddocument de 9 observations

90 %A modest 20-40% reduction in endogenous IRF-1 in ex vivo-derived peripheral CD4(+) T cells and monocytes resulted in >90% reduction in the transactivation of the HIV-1 genes (Gag, p24) and, hence, HIV replication.

KenyaVIH/sidapublié 2015Molecular therapy. Nucleic acidseurope_pmcdocument de 2 observations

80 %At baseline, 60 out of 75 participants living with HIV (80%) had previously enrolled in HIV care.

KenyaVIH/sidapublié 2023BMC health services researchPubMeddocument de 12 observations

1,23 aHRAmong sexual contacts of HIV-positive index clients in Siaya County, Kenya, non-spouse sexual contacts had an adjusted hazard ratio of 1.23 for HIV testing compared to spouse sexual contacts.

KenyaVIH/sidaobservé June 2017-August 2018publié 2020PloS onePubMeddocument de 8 observations

7 %7% of HIV-1 transmission clusters were mixed between heterosexuals and men who have sex with men (HET/MSM).

KenyaVIH/sidaobservé 2005-2019publié 2020Scientific reportsPubMeddocument de 9 observations

1,6 %Viral load monitoring reduced vertical transmission by 1.6–2.7% in newly positive women in Kenya.

KenyaVIH/sidapublié 2025AIDS (London, England)PubMeddocument de 6 observations

0,7 per_100_person_monthsThe overall rate of first viral rebound was 0.7 per 100 person-months in Malindi.

KenyaVIH/sidapublié 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 9 observations

287 clientsFrom November 2020 to October 2021, 287 out of 476 eligible clients were initiated on PrEP at private pharmacies in Kenya.

KenyaVIH/sidaobservé November 2020 to October 2021publié 2023Journal of the International AIDS Societyeurope_pmcdocument de 12 observationsDOI 10.1002/jia2.26131

17 %Among 600 sexually active women living with HIV aged 18–69 attending the Comprehensive Care Clinic at Kenyatta National Hospital in Nairobi, 17% experienced physical violence.

KenyaVIH/sidaobservé 2012publié 2020Health and human rightsPubMeddocument de 4 observations

82,3 %HIV-1 drug resistance mutations were found in 82.3% of the subjects.

KenyaVIH/sidapublié 2021MedicinePubMeddocument de 11 observations

98,5 %The sensitivity of provider-delivered HIVST at the pharmacy was 98.5% when interpreted by providers.

KenyaVIH/sidaobservé between March and June 2022publié 2023Journal of the International AIDS SocietyPubMeddocument de 9 observations

Kaposi's sarcoma is one of the most common HIV-associated cancers in sub-Saharan Africa.

KenyaKaposi's sarcoma · VIH/sidapublié 2022Journal of the International AIDS SocietyPubMeddocument de 4 observations

89 participantsBetween July 15, 2021, and Nov 2, 2022, 89 healthy adults living without HIV-1 were randomly assigned.

KenyaVIH/sidaobservé July 15, 2021 to Nov 2, 2022publié 2025The Lancet. MicrobePubMeddocument de 9 observations

90 %The proportion of adolescents and young people living with HIV on antiretroviral therapy with unsuppressed viral load who completed three enhanced adherence counselling sessions rose to 90% in the final month of the implementation period.

KenyaVIH/sidaobservé July 2020publié 2022BMJ open qualityPubMeddocument de 8 observations

90,1 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 4,243 (90.1%) had documentation of tuberculosis screening on the IPT tool before IPT initiation.

Kenyatuberculose · VIH/sidaobservé July 2015 to June 2018publié 2020PloS onePubMeddocument de 8 observations

56,7 %Treatment interruptions ≥48 hours during the past 6 months were reported by 56.7% of patients in the Democratic Republic of Congo.

KenyaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 14 observations

13,84 per_1000_person-yearsHIV incidence among adults without HIV in Kisumu County, Kenya, was 13.84 per 1000 person-years in the first year of follow-up between January 2017 and August 2021.

KenyaVIH/sidaobservé first year of follow-uppublié 2026PloS onePubMeddocument de 7 observations

28,5 %Over one quarter (28.5%) of decedents received by high-volume mortuaries in western Kenya were HIV-positive.

KenyaVIH/sidapublié 2021PloS onePubMeddocument de 14 observations

0,3 %The percentage of HIV infections with PrEP-associated nucleoside reverse transcriptase inhibitor (NRTI) drug resistance was 0.3% in the antibody rapid diagnostic testing scenario.

KenyaVIH/sidapublié 2024The lancet. HIVPubMeddocument de 6 observations

78 %78% of the participants preferred full disclosure of their HIV status by 12 years of age.

KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations

3,9 per_100_person_monthsThe overall rate of first viral rebound was 3.9 per 100 person-months in Nakuru.

KenyaVIH/sidapublié 2020International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 9 observations

92 %Among HIV-infected children in Kenya, 92% were receiving antiretroviral therapy (ART) in 2018.

KenyaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 10 observations

3,64 prevalence_rate_ratioThe prevalence rate ratio for HIV counseling in intervention versus control facilities in the final study quarter was 3.64.

KenyaVIH/sidapublié 2022Implementation science : ISeurope_pmcdocument de 6 observationsDOI 10.1186/s13012-022-01242-3